Surrogate endpoints: wishful thinking or reality?

Abstract

Get full access to this article

View all access options for this article.

References

Baker SG , Kramer BS A perfect correlate does not make a surrogate. BioMed Central Medical Reseach Methodology 2003; 3: 16.

Burzykowski T. , Molenberghs G. , Buyse M. The Evalutation of Surrogate Endpoints. Springer, 2005.

Prentice RL Surrogate endpoints in clinical trials: definitions and operational criteria . Statistics in Medicine 1989; 8: 431-40.

Freedman LS , Graubard BI , Schatzkin A. Statistical validation of intermediate endpoints for chronic diseases. Statistics in Medicine 1992; 11: 167-78.

Buyse M. , Molenberghs G. The validation of surrogate endpoints in randomized experiments. Biometrics 1998; 54: 1014-29.

Molenberghs G. , Buyse M. , Geys H. , Renard D. , Burzykowski T. , Alonso A. Statistical challenges in the evaluation of surrogate endpoints in randomized trials. Controlled Clinical Trials 2002; 23: 607-25.

Daniels MJ , Hughes MD Meta-analysis for the evaluation of potential surrogate markers. Statistics in Medicine 1997; 16: 1515-1527.

Buyse M. , Molenberghs G. , Burzykowski T. , Renard D. , Geys H. The validation of surrogate endpoints in meta-analysis of randomized experiments . Biostatistics 2000; 1: 49-67.

Gail MH , Pfeiffer R. , van Houwelingen HC , Carroll RJ On meta-analytic assessment of surrogate outcomes. Biostatistics 2000; 1: 231-46.

10.

Baker SG A simple meta-analytic approach for using a binary surrogate endpoint to predict the effect of intervention on true endpoint. Biostatstics 2000; 7: 58-70.

11.

Biomarkers Definitions Working Group. Biomarkers and surrogate endpoints: preferred definitions and conceptual framework . Clinical Pharmacology and Therapy 2001; 69: 89-95.

12.

Sargent DJ , Wieand HJ , Haller DG , Gray R. Disease-free survival versus overall survival as a primary endpoint for adjuvant colon cancer studies: individual patient data form 20,898 patients on 18 randomized trials. Journal of Clinical Oncology 2005; 23: 8664-70.

13.

Meta-Analysis Group In Cancer. Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: an updated meta-analysis. Journal of Clinical Oncology 2004; 22: 3766-75.

14.

Cunningham D. , Zalcberg J. , Maroun J. , James R. , Clarke S. , Maughan TS , Vincent M. , Schulz J. , Gonzalez BM , Facchini T. Efficacy, tolerability and management of raltitrexed (TomudexTM) monotherapy in patients with advanced colorectal cancer: a review of phase II/III trials. European Journal of Cancer 2002; 38: 478-86.